 CAMBRIDGE, Mass. SALISBURY, United Kingdom--BUSINESS WIRE--KalVista Pharmaceuticals, Inc. NASDAQ: KALV, a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors, today announced it will participate in a fireside chat at the Cantor Virtual Global Healthcare Conference on Monday, September 27, 2021 at 8:40 a.m. ET. A live webcast of the presentation will be available on the Companys website at 